DSM, Crucell to expand PER.C6 technology licensing collaboration (Forbes)

AMSTERDAM (AFX) - Crucell NV and Royal DSM NV unit DSM Biologics said they will strengthen and expand their existing collaboration on Crucell's PER.C6 protein and monoclonal antibody licensing technology.

Vignette Continues Culture of Collaboration; Vignette Collaboration release 7.0 Further Integrates Collaboration Capabilities into Vignette V7 Product

AUSTIN, Texas--(BUSINESS WIRE)--Dec. 12, 2005--Vignette Corp. (NASDAQ:VIGN) today unveiled Vignette(R) Collaboration release 7.0, the latest version of its leading enterprise collaboration product that helps manage organizational processes and critical business functions by bridging information silos to create the de facto place where people work.